Showing 1 - 13 results of 13 for search 'Lamontagne, F', query time: 0.03s
Refine Results
-
1
A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial by Zampieri, FG, da Costa, BR, Vaara, ST, Lamontagne, F, Rochwerg, B, Nichol, AD, McGuinness, S, McAuley, DF, Ostermann, M, Wald, R, Bagshaw, SM
Published 2022Journal article -
2
Nutrition adequacy therapeutic enhancement in the critically ill: a randomized double‐blind, placebo‐controlled trial of the motilin receptor agonist camicinal (GSK962040): the NUT... by Deane, A, Lamontagne, F, Dukes, G, Neil, D, Vasist, L, Barton, M, Hacquoil, K, Ou, X, Richards, D, Stelfox, H, Mehta, S, Day, A, Chapman, M, Heyland, D
Published 2017Journal article -
3
Implementation of recommendations on the use of corticosteroids in severe COVID-19 by Camirand-Lemyre, F, Merson, L, Tirupakuzhi Vijayaraghavan, BK, Burrell, AJC, Citarella, BW, Domingue, M-P, Lévesque, S, Usuf, E, Wils, E-J, Ohshimo, S, Martin-Loeches, I, Sandulescu, O, Laake, JH, Lamontagne, F
Published 2023Journal article -
4
Priorities, barriers, and facilitators towards international guidelines for the delivery of supportive clinical care during an Ebola outbreak: a cross-sectional survey by Battista, M, Loignon, C, Benhadj, L, Nouvet, E, Murthy, S, Fowler, R, Adhikari, N, Haj-Moustafa, A, Salam, A, Chan, A, Mishra, S, Couturier, F, Hudon, C, Horby, P, Bedell, R, Rekart, M, Hajek, J, Lamontagne, F
Published 2019Journal article -
5
Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. by Akl, E, Briel, M, You, J, Sun, X, Johnston, B, Busse, J, Mulla, S, Lamontagne, F, Bassler, D, Vera, C, Alshurafa, M, Katsios, C, Zhou, Q, Cukierman-Yaffe, T, Gangji, A, Mills, E, Walter, S, Cook, D, Schünemann, H, Altman, D, Guyatt, G
Published 2012Journal article -
6
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact. by Akl, E, Briel, M, You, J, Lamontagne, F, Gangji, A, Cukierman-Yaffe, T, Alshurafa, M, Sun, X, Nerenberg, K, Johnston, B, Vera, C, Mills, E, Bassler, D, Salazar, A, Bhatnagar, N, Busse, J, Khalid, Z, Walter, S, Cook, D, Schünemann, H, Altman, D, Guyatt, G
Published 2009Journal article -
7
LOST to follow-up Information in Trials (LOST-IT): A protocol on the potential impact by Akl, E, Briel, M, You, J, Lamontagne, F, Gangji, A, Cukierman-Yaffe, T, Alshurafa, M, Sun, X, Nerenberg, K, Johnston, B, Vera, C, Mills, E, Bassler, D, Salazar, A, Bhatnagar, N, Busse, J, Khalid, Z, Walter, S, Cook, D, Schünemann, H, Altman, D, Guyatt, G
Published 2009Journal article -
8
Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative study. by Kasenda, B, Liu, J, Jiang, Y, Gajewski, B, Wu, C, von Elm, E, Schandelmaier, S, Moffa, G, Trelle, S, Schmitt, AM, Herbrand, AK, Gloy, V, Speich, B, Hemkens, LG, Sluka, C, McGill, K, Meade, M, Cook, D, Lamontagne, F, Tréluyer, J-M, Haidich, A-B, Ioannidis, JPA, Treweek, S, Briel, M
Published 2020Journal article -
9
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO... by Reyes, LF, Murthy, S, Garcia-Gallo, E, Irvine, M, Merson, L, Martin-Loeches, I, Rello, J, Taccone, FS, Fowler, RA, Docherty, AB, Kartsonaki, C, Aragao, I, Barrett, PW, Beane, A, Burrell, A, Cheng, MP, Christian, MD, Cidade, JP, Citarella, BW, Donnelly, CA, Fernandes, SM, French, C, Haniffa, R, Harrison, EM, Ho, AYW, Joseph, M, Khan, I, Kho, ME, Kildal, AB, Kutsogiannis, D, Lamontagne, F, Lee, TC, Bassi, GL, Lopez Revilla, JW, Marquis, C, Millar, J, Neto, R, Nichol, A, Parke, R, Pereira, R, Poli, S, Povoa, P, Ramanathan, K, Rewa, O, Riera, J, Shrapnel, S, Silva, MJ, Udy, A, Uyeki, T, Webb, SA
Published 2022Journal article -
10
Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial by Bradbury, CA, Lawler, PR, Stanworth, SJ, McVerry, BJ, McQuilten, Z, Higgins, AM, Mouncey, PR, Al-Beidh, F, Rowan, KM, Berry, LR, Lorenzi, E, Zarychanski, R, Arabi, YM, Annane, D, Beane, A, van Bentum-Puijk, W, Bhimani, Z, Bihari, S, Bonten, MJM, Brunkhorst, FM, Buzgau, A, Buxton, M, Carrier, M, Cheng, AC, Cove, M, Detry, MA, Estcourt, LJ, Fitzgerald, M, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Hills, T, Huang, DT, Horvat, CM, Hunt, BJ, Ichihara, N, Lamontagne, F, Leavis, HL, Linstrum, KM, Litton, E, Marshall, JC, McAuley, DF, McGlothlin, A, McGuinness, SP, Middeldorp, S, Montgomery, SK, Morpeth, SC, Murthy, S
Published 2022Journal article -
11
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial by Arabi, YM, Gordon, AC, Derde, LPG, Nichol, AD, Murthy, S, Beidh, FA, Annane, D, Swaidan, LA, Beane, A, Beasley, R, Berry, LR, Bhimani, Z, Bonten, MJM, Bradbury, CA, Brunkhorst, FM, Buxton, M, Buzgau, A, Cheng, A, De Jong, M, Detry, MA, Duffy, EJ, Estcourt, LJ, Fitzgerald, M, Fowler, R, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Higgins, AM, Hills, TE, Horvat, CM, Huang, DT, King, AJ, Lamontagne, F, Lawler, PR, Lewis, R, Linstrum, K, Litton, E, Lorenzi, E, Malakouti, S, McAuley, DF, McGlothlin, A, Mcguinness, S, McVerry, BJ, Montgomery, SK, Morpeth, SC, Mouncey, PR, Orr, K, Parke, R, Parker, JC
Published 2021Journal article -
12
Effect of convalescent plasma on organ support-free days in critically ill patients With COVID-19: a randomized clinical trial by Estcourt, LJ, Turgeon, AF, McQuilten, ZK, McVerry, BJ, Al-Beidh, F, Annane, D, Arabi, YM, Arnold, DM, Beane, A, Bégin, P, van Bentum-Puijk, W, Berry, LR, Bhimani, Z, Birchall, JE, Bonten, MJM, Bradbury, CA, Brunkhorst, FM, Buxton, M, Callum, JL, Chassé, M, Cheng, AC, Cove, ME, Daly, J, Derde, L, Detry, MA, De Jong, M, Evans, A, Fergusson, DA, Fish, M, Fitzgerald, M, Foley, C, Goossens, H, Gordon, AC, Gosbell, IB, Green, C, Haniffa, R, Harvala, H, Higgins, AM, Hills, TE, Hoad, VC, Horvat, C, Huang, DT, Hudson, CL, Ichihara, N, Laing, E, Lamikanra, AA, Lamontagne, F, Roberts, DJ
Published 2021Journal article -
13
Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-cap randomized clinical trial by Higgins, AM, Berry, LR, Lorenzi, E, Murthy, S, McQuilten, Z, Mouncey, PR, Al-Beidh, F, Annane, D, Arabi, YM, Beane, A, van Bentum-Puijk, W, Bhimani, Z, Bonten, MJM, Bradbury, CA, Brunkhorst, FM, Burrell, A, Buzgau, A, Buxton, M, Charles, WN, Cove, M, Detry, MA, Estcourt, LJ, Fagbodun, EO, Fitzgerald, M, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Hills, T, Horvat, CM, Huang, DT, Ichihara, N, Lamontagne, F, Marshall, JC, McAuley, DF, McGlothlin, A, McGuinness, SP, McVerry, BJ, Neal, MD, Nichol, AD, Parke, RL, Parker, JC, Parry-Billings, K, Peters, SEC, Reyes, LF, Rowan, KM, Saito, H, Santos, MS, Saunders, CT
Published 2022Journal article